Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,957 total articles

American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information

American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information

American Assets Trust, Inc., a U.S.-based real estate investment trust (REIT) specializing in office, retail, and residential properties primarily in high-barrier U.S. markets, will report its first quarter 2026 earnings on April 28, 2026, followed by a conference call on April 29. The company provided information on how to access the call and webc…

KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon

KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon

KBR's Mission Technology Solutions business is playing a key role in supporting NASA's Artemis II mission—the first human mission beyond low-Earth orbit since 1972—by providing astronaut training, mission planning, real-time spacecraft monitoring, and health support. Their engineering expertise also advances NASA's Space Launch System. This mission…

Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release

Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release

Cycurion, Inc., a cybersecurity and AI solutions company listed on Nasdaq, announced it has taken legal action against ACCESS Newswire and others responsible for distributing an unauthorized and fraudulent press release falsely alleging a company acquisition. The false release caused market disruption and abnormal trading. Cycurion is pursuing sign…

Carpenter Technology Announces Conference Call and Webcast

Carpenter Technology Announces Conference Call and Webcast

Carpenter Technology Corporation will host a conference call and webcast on April 29, 2026, to discuss their third quarter fiscal 2026 financial results ending March 31, 2026. The call will follow the earnings release prior to market open and provide insights into the company's performance in various high-performance specialty alloy markets.

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Inc. successfully completed its initial clinical Cut-off Study for its Intelligent Fingerprinting Drug Screening System detecting opiate codeine, progressing its FDA 510(k) submission process. The company has initiated the second phase clinical studies, including Method Comparison, Usability, and Interference Testing, targ…

Small Business Sales Grew Steadily in March as Higher Ticket Sizes Offset Softer Foot Traffic, Fiserv Data Shows

Small Business Sales Grew Steadily in March as Higher Ticket Sizes Offset Softer Foot Traffic, Fiserv Data Shows

Fiserv, Inc. released its March 2026 Small Business Index indicating steady growth in U.S. small business sales, supported by higher average ticket sizes which offset slower foot traffic. The data highlights cautious consumer behavior influenced by rising energy prices, with increased spending at gasoline stations but moderated restaurant and groce…

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

Ultragenyx announced the FDA’s acceptance of the resubmitted Biologics License Application for UX111, an AAV9 gene therapy targeting Sanfilippo syndrome Type A (MPS IIIA), a rare and fatal neurodegenerative disease in children. The FDA granted Priority Review with an expected decision date of September 19, 2026. Clinical data show durable treatment…

CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026

CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026

CSW Industrials announced an 11% increase in its quarterly dividend to $0.30 per share and repurchased approximately $35 million in shares during the fiscal fourth quarter of 2026. The company highlighted its strong balance sheet, consistent cash flow, and profitability, supporting continued capital return strategies including dividends and share b…

Toro Corp. Announces $60.0 Million Revolving Credit Facility

Toro Corp. Announces $60.0 Million Revolving Credit Facility

Toro Corp., a NASDAQ-listed global energy transportation services provider, announced a $60 million revolving credit facility with a leading European financial institution. The five-year facility will be secured by a first priority mortgage on four of the Company's vessels, with proceeds earmarked for general corporate use.

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MIMEDX to Sponsor Leading Advanced Wound Care Conferences

MiMedx Group, Inc. announced its sponsorship and active participation in two leading wound care conferences—SAWC Spring 2026 and MedStar Georgetown's Diabetic Limb Salvage Conference. The company will highlight its expanded advanced wound care portfolio and present new scientific data, emphasizing clinical evidence and innovative treatments geared …

FinWise Bancorp to Host First Quarter 2026 Earnings Conference Call and Webcast on Thursday, April 30, 2026

FinWise Bancorp to Host First Quarter 2026 Earnings Conference Call and Webcast on Thursday, April 30, 2026

FinWise Bancorp, a US-based bank specializing in fintech banking and payments solutions, has scheduled its first quarter 2026 earnings release and conference call for April 30, 2026. The company enables fintech brands with scalable API-driven lending and payments programs and is expanding its services to include payments and BIN sponsorship offerin…

Primech A & P Secures US$24.0 Million Multi-Year Government-Linked Contract for Integrated Cleaning Services Across Six Major Hawker Centres in Singapore

Primech A & P Secures US$24.0 Million Multi-Year Government-Linked Contract for Integrated Cleaning Services Across Six Major Hawker Centres in Singapore

Primech Holdings Limited, a Nasdaq-listed company, announced that its subsidiary, Primech A & P, has secured a US$24 million contract to deliver integrated cleaning services across six prominent hawker and food centres in Singapore. The 4+1-year performance-based contract emphasizes technology-driven operational efficiencies including automation an…

IP Strategy Publishes Monthly Validator Update

IP Strategy Publishes Monthly Validator Update

IP Strategy Holdings, Inc. (NASDAQ: IPST) provided its monthly update highlighting its validator operations on the Story blockchain network. Since launching in September 2025, the company's validator has demonstrated near-perfect uptime and transitioned to a long-term staking model, expected to increase yields. For March 2026, the company earned ov…

BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure

BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure

BioCardia has submitted clinical data to the FDA and requested a meeting under the FDA's Breakthrough Designation to discuss accelerated approval of its CardiAMP System for treating ischemic heart failure with reduced ejection fraction. The CardiAMP HF Trial demonstrated significant clinical benefits in a high-risk patient subgroup, including subst…